Gram-negative bacterial sensors for eukaryotic signal molecules

Sensors

Volumn 9, Issue 9, 2009, Pages 6967-6990

  Lesouhaitier, Olivier ^a   Veron, Wilfried ^a   Chapalain, Annelise ^a   Madi, Amar ^a   Blier, Anne Sophie ^a   Dagorn, Audrey ^a   Connil, Nathalie ^a   Chevalier, Sylvie ^a   Orange, Nicole ^a   Feuilloley, Marc ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Cytokines; Hormones; Host pathogen interactions; Neurotransmitters; Pathogens; Pseudomonas; Sensors; Virulence

Indexed keywords

CYTOKINES; HOST-PATHOGEN INTERACTIONS; NEUROTRANSMITTERS; PSEUDOMONAS; VIRULENCE;

BACTERIA; CYTOLOGY; ESCHERICHIA COLI; HORMONES; INTERFERONS; PHYSIOLOGY; SENSORS;

PATHOGENS;

EID: 70350004980     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s90906967     Document Type: Review

References (158)

1. Henderson, B.; Wilson, M. Homo bacteriens and a network of surprises. J. Med. Microbiol. 1996, 45, 393-394.
2. Honey, K. Good bugs, bad bugs: learning what we can from the microorganisms that colonize our bodies. J. Clin. Invest. 2008, 118, 3817.
3. Steinert, M.; Hentschel, U.; Hacker, J. Symbiosis and pathogenesis: evolution of the microbe-host interaction. Naturwissenschaften 2000, 87, 1-11.
4. Dethlefsen, L.; McFall-Ngai, M.; Relman, D.A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007, 449, 811-818.
5. Inglis, R.F.; Gardner, A.; Cornelis, P.; Buckling, A. Spite and virulence in the bacterium Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 2009, 106, 5703-5707.
6. Rosenberger, C.M.; Finlay, B.B. Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat. Rev. Mol. Cell. Biol. 2003, 4, 385-396.
7. Cossart, P.; Sansonetti, P.J. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 2004, 304, 242-248.
8. Wang, M.; Shakhatreh, M.A.; James, D.; Liang, S.; Nishiyama, S.; Yoshimura, F.; Demuth, D.R.; Hajishengallis, G. Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J. Immunol. 2007, 179, 2349-2358.
9. Mitchell, J.A.; Paul-Clark, M.J.; Clarke, G.W.; McMaster, S.K.; Cartwright, N. Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. J. Endocrinol. 2007, 193, 323-330.
10. Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001, 1, 135-145.
11. Lien, E.; Means, T.K.; Heine, H.; Yoshimura, A.; Kusumoto, S.; Fukase, K.; Fenton, M.J.; Oikawa, M.; Qureshi, N.; Monks, B. et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 2000, 105, 497-504.
12. Raetz, C.R.; Whitfield, C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 2002, 71, 635-700.
13. Schurr, J.R.; Young, E.; Byrne, P.; Steele, C.; Shellito, J.E.; Kolls, J.K. Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria. Infect. Immun. 2005, 73, 532-545.
14. Caroff, M.; Karibian, D. Structure of bacterial lipopolysaccharides. Carbohydr. Res. 2003, 338, 2431-2447.
15. Kawasaki, K.; Ernst, R.K.; Miller, S.I. Deacylation and palmitoylation of lipid A by Salmonellae outer membrane enzymes modulate host signaling through Toll-like receptor 4. J. Endotoxin Res. 2004, 10, 439-444.
16. Kawahara, K.; Tsukano, H.; Watanabe, H.; Lindner, B.; Matsuura, M. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect. Immun. 2002, 70, 4092-4098.
17. Ernst, R.K.; Adams, K.N.; Moskowitz, S.M.; Kraig, G.M.; Kawasaki, K.; Stead, C.M.; Trent, M.S.; Miller, S.I. The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. J. Bacteriol. 2006, 188, 191-201.
18. Padda, J.S.; Schryvers, A.B. N-linked oligosaccharides of human transferrin are not required for binding to bacterial transferrin receptors. Infect. Immun. 1990, 58, 2972-2976.
19. Ullberg, M.; Kronvall, G.; Karlsson, I.; Wiman, B. Receptors for human plasminogen on gram-negative bacteria. Infect. Immun. 1990, 58, 21-25.
20. Lopes, J.D.; dos Reis, M.; Brentani, R.R. Presence of laminin receptors in Staphylococcus aureus. Science 1985, 229, 275-277.
21. Holderbaum, D.; Hall, G.S.; Ehrhart, L.A. Collagen binding to Staphylococcus aureus. Infect. Immun. 1986, 54, 359-364.
22. Visai, L.; Speziale, P.; Bozzini, S. Binding of collagens to an enterotoxigenic strain of Escherichia coli. Infect. Immun. 1990, 58, 449-455.
23. Rebiere-Huet, J.; Guerillon, J.; Pimenta, A.L.; Di Martino, P.; Orange, N.; Hulen, C. Porins of Pseudomonas fluorescens MFO as fibronectin-binding proteins. FEMS Microbiol. Lett. 2002, 215, 121-126.
24. Hoch, J.A. Two-component and phosphorelay signal transduction. Curr. Opin. Microbiol. 2000, 3, 165-170.
25. Beier, D.; Gross, R. Regulation of bacterial virulence by two-component systems. Curr. Opin. Microbiol. 2006, 9, 143-152.
26. Anantharaman, V.; Aravind, L. Application of comparative genomics in the identification and analysis of novel families of membrane-associated receptors in bacteria. BMC Genomics 2003, 4, 34.
27. Nikolskaya, A.N.; Mulkidjanian, A.Y.; Beech, I.B.; Galperin, M.Y. MASE1 and MASE2: two novel integral membrane sensory domains. J. Mol. Microbiol. Biotechnol. 2003, 5, 11-16.
28. Zhulin, I.B.; Nikolskaya, A.N.; Galperin, M.Y. Common extracellular sensory domains in transmembrane receptors for diverse signal transduction pathways in bacteria and archaea. J. Bacteriol. 2003, 185, 285-294.
29. Tasneem, A.; Iyer, L.M.; Jakobsson, E.; Aravind, L. Identification of the prokaryotic ligand- gated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels. Genome Biol. 2005, 6, R4.
30. Anantharaman, V.; Aravind, L. MEDS and PocR are novel domains with a predicted role in sensing simple hydrocarbon derivatives in prokaryotic signal transduction systems. Bioinformatics 2005, 21, 2805-2811.
31. Galperin, M.Y.; Nikolskaya, A.N. Identification of sensory and signal-transducing domains in two-component signaling systems. Methods Enzymol. 2007, 422, 47-74.
32. Ravichandran, A.; Sugiyama, N.; Tomita, M.; Swarup, S.; Ishihama, Y. Ser/Thr/Tyr phosphoproteome analysis of pathogenic and non-pathogenic Pseudomonas species. Proteomics 2009, 9, 2764-2775.
33. Clarke, M.B.; Hughes, D.T.; Zhu, C.; Boedeker, E.C.; Sperandio, V. The QseC sensor kinase: a bacterial adrenergic receptor. Proc. Natl. Acad. Sci. USA 2006, 103, 10420-10425.
34. Lyte, M.; Ernst, S. Catecholamine induced growth of gram negative bacteria. Life Sci. 1992, 50, 203-212.
35. Lyte, M.; Ernst, S. Alpha and beta adrenergic receptor involvement in catecholamine-induced growth of gram-negative bacteria. Biochem. Biophys. Res. Commun. 1993, 190, 447-452.
36. Lyte, M. Microbial endocrinology and infectious disease in the 21st century. Trends Microbiol. 2004, 12, 14-20.
37. Freestone, P.P.; Lyte, M. Microbial endocrinology: experimental design issues in the study of interkingdom signalling in infectious disease. Adv. Appl. Microbiol. 2008, 64, 75-105.
38. Freestone, P.P.; Sandrini, S.M.; Haigh, R.D.; Lyte, M. Microbial endocrinology: how stress influences susceptibility to infection. Trends Microbiol. 2008, 16, 55-64.
39. Lyte, M.; Arulanandam, B.; Nguyen, K.; Frank, C.; Erickson, A.; Francis, D. Norepinephrine induced growth and expression of virulence associated factors in enterotoxigenic and enterohemorrhagic strains of Escherichia coli. Adv. Exp. Med. Biol. 1997, 412, 331-339.
40. Porat, R.; Clark, B.D.; Wolff, S.M.; Dinarello, C.A. Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 1991, 254, 430-432.
41. Hogan, J.S.; Todhunter, D.A.; Smith, K.L.; Schoenberger, P.S.; Sordillo, L.M. Growth responses of coliform bacteria to recombinant bovine cytokines. J. Dairy Sci. 1993, 76, 978-982.
42. Woods, D.E.; Jones, A.L.; Hill, P.J. Interaction of insulin with Pseudomonas pseudomallei. Infect. Immun. 1993, 61, 4045-4050.
43. Yamashita, K.; Kaneko, H.; Yamamoto, S.; Konagaya, T.; Kusugami, K.; Mitsuma, T. Inhibitory effect of somatostatin on Helicobacter pylori proliferation in vitro. Gastroenterology 1998, 115, 1123-1130.
44. Veron, W.; Lesouhaitier, O.; Pennanec, X.; Rehel, K.; Leroux, P.; Orange, N.; Feuilloley, M.G. Natriuretic peptides affect Pseudomonas aeruginosa and specifically modify lipopolysaccharide biosynthesis. FEBS J. 2007, 274, 5852-5864.
45. Renaud, M.; Miget, A. Rôle favorisant des perturbations locales causées par l'adrénaline sur le développement des infections microbiennes. C. R. Séances Soc. Biol. Fil. 1930, 103, 1052-1054.
46. Lyte, M. The role of microbial endocrinology in infectious disease. J. Endocrinol. 1993, 137, 343-345.
47. Freestone, P.P.; Haigh, R.D.; Williams, P.H.; Lyte, M. Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers. FEMS Microbiol. Lett. 1999, 172, 53-60.
48. Anderson, M.T.; Armstrong, S.K. The Bordetella bfe system: growth and transcriptional response to siderophores, catechols, and neuroendocrine catecholamines. J. Bacteriol. 2006, 188, 5731-5740.
49. Lyte, M.; Arulanandam, B.P.; Frank, C.D. Production of Shiga-like toxins by Escherichia coli O157:H7 can be influenced by the neuroendocrine hormone norepinephrine. J. Lab. Clin. Med. 1996, 128, 392-398.
50. Lyte, M.; Erickson, A.K.; Arulanandam, B.P.; Frank, C.D.; Crawford, M.A.; Francis, D.H. Norepinephrine-induced expression of the K99 pilus adhesin of enterotoxigenic Escherichia coli. Biochem. Biophys. Res. Commun. 1997, 232, 682-686.
51. Lyte, M.; Freestone, P.P.; Neal, C.P.; Olson, B.A.; Haigh, R.D.; Bayston, R.; Williams, P.H. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet 2003, 361, 130-135.
52. Sperandio, V.; Torres, A.G.; Jarvis, B.; Nataro, J.P.; Kaper, J.B. Bacteria-host communication: the language of hormones. Proc. Natl. Acad. Sci. USA 2003, 100, 8951-8956.
53. Rahman, H.; Reissbrodt, R.; Tschape, H. Effect of norepinephrine on growth of Salmonella and its enterotoxin production. Indian J. Exp. Biol. 2000, 38, 285-286.
54. Kinney, K.S.; Austin, C.E.; Morton, D.S.; Sonnenfeld, G. Catecholamine enhancement of Aeromonas hydrophila growth. Microb. Pathog. 1999, 26, 85-91.
55. O'Donnell, P.M.; Aviles, H.; Lyte, M.; Sonnenfeld, G. Enhancement of in vitro growth of pathogenic bacteria by norepinephrine: importance of inoculum density and role of transferrin. Appl. Environ. Microbiol. 2006, 72, 5097-5099.
56. Coulanges, V.; Andre, P.; Vidon, D.J. Effect of siderophores, catecholamines, and catechol compounds on Listeria spp. Growth in iron-complexed medium. Biochem. Biophys. Res. Commun. 1998, 249, 526-530.
57. Freestone, P.P.; Lyte, M.; Neal, C.P.; Maggs, A.F.; Haigh, R.D.; Williams, P.H. The mammalian neuroendocrine hormone norepinephrine supplies iron for bacterial growth in the presence of transferrin or lactoferrin. J. Bacteriol. 2000, 182, 6091-6098.
58. Freestone, P.P.; Haigh, R.D.; Lyte, M. Blockade of catecholamine-induced growth by adrenergic and dopaminergic receptor antagonists in Escherichia coli O157:H7, Salmonella enterica and Yersinia enterocolitica. BMC Microbiol. 2007, 7, 8.
59. Freestone, P.P.; Haigh, R.D.; Lyte, M. Specificity of catecholamine-induced growth in Escherichia coli O157:H7, Salmonella enterica and Yersinia enterocolitica. FEMS Microbiol. Lett. 2007, 269, 221-228.
60. Sperandio, V.; Li, C.C.; Kaper, J.B. Quorum-sensing Escherichia coli regulator A: a regulator of the LysR family involved in the regulation of the locus of enterocyte effacement pathogenicity island in enterohemorrhagic E. coli. Infect. Immun. 2002, 70, 3085-3093.
61. Sperandio, V.; Torres, A.G.; Kaper, J.B. Quorum sensing Escherichia coli regulators B and C (QseBC): a novel two-component regulatory system involved in the regulation of flagella and motility by quorum sensing in E. coli. Mol. Microbiol. 2002, 43, 809-821.
62. Hughes, D.T.; Sperandio, V. Inter-kingdom signalling: communication between bacteria and their hosts. Nat. Rev. Microbiol. 2008, 6, 111-120.
63. Walters, M.; Sperandio, V. Quorum sensing in Escherichia coli and Salmonella. Int. J. Med. Microbiol. 2006, 296, 125-131.
64. Rasko, D.A.; Moreira, C.G.; Li de, R.; Reading, N.C.; Ritchie, J.M.; Waldor, M.K.; Williams, N.; Taussig, R.; Wei, S.; Roth, M. et al. Targeting QseC signaling and virulence for antibiotic development. Science 2008, 321, 1078-1080.
65. Reading, N.C.; Rasko, D.A.; Torres, A.G.; Sperandio, V. The two-component system QseEF and the membrane protein QseG link adrenergic and stress sensing to bacterial pathogenesis. Proc. Natl. Acad. Sci. USA 2009, 106, 5889-5894.
66. Bearson, B.L.; Bearson, S.M. The role of the QseC quorum-sensing sensor kinase in colonization and norepinephrine-enhanced motility of Salmonella enterica serovar Typhimurium. Microb. Pathog. 2008, 44, 271-278.
67. Merighi, M.; Septer, A.N.; Carroll-Portillo, A.; Bhatiya, A.; Porwollik, S.; McClelland, M.; Gunn, J.S. Genome-wide analysis of the PreA/PreB (QseB/QseC) regulon of Salmonella enterica serovar Typhimurium. BMC Microbiol. 2009, 9, 42.
68. Belay, T.; Sonnenfeld, G. Differential effects of catecholamines on in vitro growth of pathogenic bacteria. Life Sci. 2002, 71, 447-456.
69. Alverdy, J.; Holbrook, C.; Rocha, F.; Seiden, L.; Wu, R.L.; Musch, M.; Chang, E.; Ohman, D.; Suh, S. Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann. Surg. 2000, 232, 480-489.
70. Laughlin, R.S.; Musch, M.W.; Hollbrook, C.J.; Rocha, F.M.; Chang, E.B.; Alverdy, J.C. The key role of Pseudomonas aeruginosa PA-I lectin on experimental gut-derived sepsis. Ann. Surg. 2000, 232, 133-142.
71. Wagner, J.; Short, K.; Catto-Smith, A.G.; Cameron, D.J.; Bishop, R.F.; Kirkwood, C.D. Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn's disease. PLoS ONE 2008, 3, e3578.
72. Owens, D.F.; Kriegstein, A.R. Is there more to GABA than synaptic inhibition? Nat. Rev. Neurosci. 2002, 3, 715-727.
73. Dover, S.; Halpern, Y.S. Utilization of -aminobutyric acid as the sole carbon and nitrogen source by Escherichia coli K-12 mutants. J. Bacteriol. 1972, 109, 835-843.
74. Higuchi, T.; Hayashi, H.; Abe, K. Exchange of glutamate and gamma-aminobutyrate in a Lactobacillus strain. J. Bacteriol. 1997, 179, 3362-3364.
75. Noe, F.F.; Nickerson, W.J. Metabolism of 2-pyrrolidone and gamma-aminobutyric acid by Pseudomonas aeruginosa. J. Bacteriol. 1958, 75, 674-681.
76. Scott, E.M.; Jakoby, W.B. Soluble gamma-aminobutyric-glutamic transaminase from Pseudomonas fluorescens. J. Biol. Chem. 1959, 234, 932-936.
77. Minuk, G.Y. Gamma-aminobutyric acid (GABA) production by eight common bacterial pathogens. Scand. J. Infect. Dis. 1986, 18, 465-467.
78. Mountfort, D.O.; Pybus, V. Regulatory Influences on the Production of Gamma-Aminobutyric Acid by a Marine Pseudomonad. Appl. Environ. Microbiol. 1992, 58, 237-242.
79. Morse, D.E.; Hooker, N.; Duncan, H.; Jensen, L. ggr-Aminobutyric Acid, a Neurotransmitter, Induces Planktonic Abalone Larvae to Settle and Begin Metamorphosis. Science 1979, 204, 407-410.
80. Morse, D.E.; Duncan, H.; Hooker, N.; Baloun, A.; Young, G. GABA induces behavioral and developmental metamorphosis in planktonic molluscan larvae. Fed. Proc. 1980, 39, 3237-3241.
81. Guthrie, G.D.; Nicholson-Guthrie, C.S. gamma-Aminobutyric acid uptake by a bacterial system with neurotransmitter binding characteristics. Proc. Natl. Acad. Sci. USA 1989, 86, 7378-7381.
82. Guthrie, G.D.; Nicholson-Guthrie, C.S.; Leary, H.L., Jr. A bacterial high-affinity GABA binding protein: isolation and characterization. Biochem. Biophys. Res. Commun. 2000, 268, 65-68.
83. Watanabe, M.; Maemura, K.; Kanbara, K.; Tamayama, T.; Hayasaki, H. GABA and GABA receptors in the central nervous system and other organs. Int. Rev. Cytol. 2002, 213, 1-47.
84. Morera, S.; Gueguen-Chaignon, V.; Raffoux, A.; Faure, D. Cloning, purification, crystallization and preliminary X-ray analysis of a bacterial GABA receptor with a Venus flytrap fold. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2008, 64, 1153-1155.
85. Chevrot, R.; Rosen, R.; Haudecoeur, E.; Cirou, A.; Shelp, B.J.; Ron, E.; Faure, D. GABA controls the level of quorum-sensing signal in Agrobacterium tumefaciens. Proc. Natl. Acad. Sci. USA 2006, 103, 7460-7464.
86. Chou, H.T.; Kwon, D.H.; Hegazy, M.; Lu, C.D. Transcriptome analysis of agmatine and putrescine catabolism in Pseudomonas aeruginosa PAO1. J. Bacteriol. 2008, 190, 1966-1975.
87. Chapalain, A.; Chevalier, S.; Lesouhaitier, O.; Merieau, A.; Orange, N.; Feuilloley, M.G. Involvement of gamma-aminobutyric acid (GABA) in the regulation of adhesion and virulence in Pseudomonas fluorescens MF37 and Pseudomonas aeruginosa PAO1. In Proceedings of the Swiss Molecular Microbiology: Microbial evolution and adaptation Symposium, Villar-sur-Ollon, The Switzerland, June 11-13, 2007; p. 1.
88. Lambert, G.P. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J. Anim. Sci. 2009, 87, E101-108.
89. Denis, M.; Campbell, D.; Gregg, E.O. Interleukin-2 and granulocyte-macrophage colony-stimulating factor stimulate growth of a virulent strain of Escherichia coli. Infect. Immun. 1991, 59, 1853-1856.
90. Meduri, G.U.; Kanangat, S.; Stefan, J.; Tolley, E.; Schaberg, D. Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am. J. Respir. Crit. Care Med. 1999, 160, 961-967.
91. Luo, G.; Niesel, D.W.; Shaban, R.A.; Grimm, E.A.; Klimpel, G.R. Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect. Immun. 1993, 61, 830-835.
92. Meduri, G.U. Clinical review: a paradigm shift: the bidirectional effect of inflammation on bacterial growth. Clinical implications for patients with acute respiratory distress syndrome. Crit. Care 2002, 6, 24-29.
93. Zav'yalov, V.P.; Chernovskaya, T.V.; Navolotskaya, E.V.; Karlyshev, A.V.; MacIntyre, S.; Vasiliev, A.M.; Abramov, V.M. Specific high affinity binding of human interleukin 1 beta by Caf1A usher protein of Yersinia pestis. FEBS Lett. 1995, 371, 65-68.
94. Schall, T.J.; Lewis, M.; Koller, K.J.; Lee, A.; Rice, G.C.; Wong, G.H.; Gatanaga, T.; Granger, G.A.; Lentz, R.; Raab, H. et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990, 61, 361-370.
95. Van Delden, C.; Iglewski, B.H. Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg. Infect. Dis. 1998, 4, 551-560.
96. Wu, L.; Estrada, O.; Zaborina, O.; Bains, M.; Shen, L.; Kohler, J.E.; Patel, N.; Musch, M.W.; Chang, E.B.; Fu, Y.X. et al. Recognition of host immune activation by Pseudomonas aeruginosa. Science 2005, 309, 774-777.
97. Risdahl, J.M.; Khanna, K.V.; Peterson, P.K.; Molitor, T.W. Opiates and infection. J. Neuroimmunol. 1998, 83, 4-18.
98. Peterson, P.K.; Molitor, T.W.; Chao, C.C. The opioid-cytokine connection. J. Neuroimmunol. 1998, 83, 63-69.
99. Zaborina, O.; Lepine, F.; Xiao, G.; Valuckaite, V.; Chen, Y.; Li, T.; Ciancio, M.; Zaborin, A.; Petroff, E.; Turner, J.R. et al. Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog. 2007, 3, e35.
100. Marinova, Z.; Vukojevic, V.; Surcheva, S.; Yakovleva, T.; Cebers, G.; Pasikova, N.; Usynin, I.; Hugonin, L.; Fang, W.; Hallberg, M. et al. Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission. J. Biol. Chem. 2005, 280, 26360-26370.
101. Xiao, G.; Deziel, E.; He, J.; Lepine, F.; Lesic, B.; Castonguay, M.H.; Milot, S.; Tampakaki, A.P.; Stachel, S.E.; Rahme, L.G. MvfR, a key Pseudomonas aeruginosa pathogenicity LTTR-class regulatory protein, has dual ligands. Mol. Microbiol. 2006, 62, 1689-1699.
102. Pritchard, D.; Hooi, D.; Watson, E.; Chow, S.; Telford, G.; Bycroft, B.; Chhabra, S.R.; Harty, C.; Camara, M.; Diggle, S.P. Bacterial Quorum Sensing Signalling Molecules as Immune Modulators; Cambridge University Press: Cambridge, UK, 2003.
103. Hooi, D.S.; Bycroft, B.W.; Chhabra, S.R.; Williams, P.; Pritchard, D.I. Differential immune modulatory activity of Pseudomonas aeruginosa quorum-sensing signal molecules. Infect. Immun. 2004, 72, 6463-6470.
104. Pritchard, D.I. Immune modulation by Pseudomonas aeruginosa quorum-sensing signal molecules. Int. J. Med. Microbiol. 2006, 296, 111-116.
105. Skindersoe, M.E.; Zeuthen, L.H.; Brix, S.; Fink, L.N.; Lazenby, J.; Whittall, C.; Williams, P.; Diggle, S.P.; Froekiaer, H.; Cooley, M. et al. Pseudomonas aeruginosa quorum-sensing signal molecules interfere with dendritic cell-induced T-cell proliferation. FEMS Immunol. Med. Microbiol. 2009, 55, 335-345.
106. Waterer, G.W.; Wunderink, R.G. Increasing threat of Gram-negative bacteria. Crit. Care Med. 2001, 29, N75-81.
107. Cegelski, L.; Marshall, G.R.; Eldridge, G.R.; Hultgren, S.J. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol. 2008, 6, 17-27.
108. Hancock, R.E. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 2001, 1, 156-164.
109. Hancock, R.E.; Patrzykat, A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord. 2002, 2, 79-83.
110. Hoffmann, J.A.; Kafatos, F.C.; Janeway, C.A.; Ezekowitz, R.A. Phylogenetic perspectives in innate immunity. Science 1999, 284, 1313-1318.
111. Lehrer, R.I.; Ganz, T. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 1999, 11, 23-27.
112. Hancock, R.E.; Chapple, D.S. Peptide antibiotics. Antimicrob. Agents Chemother. 1999, 43, 1317-1323.
113. Bader, M.W.; Sanowar, S.; Daley, M.E.; Schneider, A.R.; Cho, U.; Xu, W.; Klevit, R.E.; Le Moual, H.; Miller, S.I. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 2005, 122, 461-472.
114. Kraus, D.; Peschel, A. Molecular mechanisms of bacterial resistance to antimicrobial peptides. Curr. Top. Microbiol. Immunol. 2006, 306, 231-250.
115. Peschel, A.; Sahl, H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 2006, 4, 529-536.
116. Peschel, A. How do bacteria resist human antimicrobial peptides? Trends Microbiol. 2002, 10, 179-186.
117. Moss, J.E.; Fisher, P.E.; Vick, B.; Groisman, E.A.; Zychlinsky, A. The regulatory protein PhoP controls susceptibility to the host inflammatory response in Shigella flexneri. Cell. Microbiol. 2000, 2, 443-452.
118. Llama-Palacios, A.; Lopez-Solanilla, E.; Poza-Carrion, C.; Garcia-Olmedo, F.; Rodriguez-Palenzuela, P. The Erwinia chrysanthemi phoP-phoQ operon plays an important role in growth at low pH, virulence and bacterial survival in plant tissue. Mol. Microbiol. 2003, 49, 347-357.
119. Macfarlane, E.L.; Kwasnicka, A.; Hancock, R.E. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 2000, 146, 2543-2554.
120. Gooderham, W.J.; Gellatly, S.L.; Sanschagrin, F.; McPhee, J.B.; Bains, M.; Cosseau, C.; Levesque, R.C.; Hancock, R.E. The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa. Microbiology 2009, 155, 699-711.
121. Cutuli, M.; Cristiani, S.; Lipton, J.M.; Catania, A. Antimicrobial effects of alpha-MSH peptides. J. Leukoc. Biol. 2000, 67, 233-239.
122. Metz-Boutigue, M.H.; Goumon, Y.; Lugardon, K.; Strub, J.M.; Aunis, D. Antibacterial peptides are present in chromaffin cell secretory granules. Cell. Mol. Neurobiol. 1998, 18, 249-266.
123. Metz-Boutigue, M.H.; Kieffer, A.E.; Goumon, Y.; Aunis, D. Innate immunity: involvement of new neuropeptides. Trends Microbiol. 2003, 11, 585-592.
124. Brogden, K.A.; Guthmiller, J.M.; Salzet, M.; Zasloff, M. The nervous system and innate immunity: the neuropeptide connection. Nat. Immunol. 2005, 6, 558-564.
125. Hansen, C.J.; Burnell, K.K.; Brogden, K.A. Antimicrobial activity of Substance P and Neuropeptide Y against laboratory strains of bacteria and oral microorganisms. J. Neuroimmunol. 2006, 177, 215-218.
126. El Karim, I.A.; Linden, G.J.; Orr, D.F.; Lundy, F.T. Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J. Neuroimmunol. 2008, 200, 11-16.
127. Kanai, K.; Kondo, E.; Kurata, T. Affinity and response of Burkholderia pseudomallei and Burkholderia cepacia to insulin. Southeast Asian J. Trop. Med. Public Health 1996, 27, 584-591.
128. Simpson, A.J.; Wuthiekanun, V. Interaction of insulin with Burkholderia pseudomallei may be caused by a preservative. J. Clin. Pathol. 2000, 53, 159-160.
129. Currie, B. Pseudomonas pseudomallei-insulin interaction. Infect. Immun. 1995, 63, 3745.
130. Chowers, M.Y.; Keller, N.; Bar-Meir, S.; Chowers, Y. A defined human gastrin sequence stimulates the growth of Helicobacter pylori. FEMS Microbiol. Lett. 2002, 217, 231-236.
131. Chowers, M.Y.; Keller, N.; Tal, R.; Barshack, I.; Lang, R.; Bar-Meir, S.; Chowers, Y. Human gastrin: a Helicobacter pylori--specific growth factor. Gastroenterology 1999, 117, 1113-1118.
132. Lamberts, S.W.; Krenning, E.P.; Reubi, J.C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 1991, 12, 450-482.
133. Hofland, L.J.; Lamberts, S.W. The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr. Rev. 2003, 24, 28-47.
134. Bulet, P.; Stocklin, R.; Menin, L. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 2004, 198, 169-184.
135. Krause, A.; Liepke, C.; Meyer, M.; Adermann, K.; Forssmann, W.G.; Maronde, E. Human natriuretic peptides exhibit antimicrobial activity. Eur. J. Med. Res. 2001, 6, 215-218.
136. Kourie, J.I. Synthetic mammalian C-type natriuretic peptide forms large cation channels. FEBS Lett. 1999, 445, 57-62.
137. Kalra, P.R.; Clague, J.R.; Bolger, A.P.; Anker, S.D.; Poole-Wilson, P.A.; Struthers, A.D.; Coats, A.J. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation 2003, 107, 571-573.
138. Rudiger, A.; Gasser, S.; Fischler, M.; Hornemann, T.; von Eckardstein, A.; Maggiorini, M. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit. Care Med. 2006, 34, 2140-2144.
139. Post, F.; Weilemann, L.S.; Messow, C.M.; Sinning, C.; Munzel, T. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Crit. Care Med. 2008, 36, 3030-3037.
140. Vila, G.; Resl, M.; Stelzeneder, D.; Struck, J.; Maier, C.; Riedl, M.; Hulsmann, M.; Pacher, R.; Luger, A.; Clodi, M. Plasma NT-proBNP increases in response to LPS administration in healthy men. J. Appl. Physiol. 2008, 105, 1741-1745.
141. Veron, W.; Orange, N.; Feuilloley, M.G.; Lesouhaitier, O. Natriuretic peptides modify Pseudomonas fluorescens cytotoxicity by regulating cyclic nucleotides and modifying LPS structure. BMC Microbiol. 2008, 8, 114.
142. Wolfgang, M.C.; Lee, V.T.; Gilmore, M.E.; Lory, S. Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway. Dev. Cell 2003, 4, 253-263.
143. Lory, S.; Wolfgang, M.; Lee, V.; Smith, R. The multi-talented bacterial adenylate cyclases. Int. J. Med. Microbiol. 2004, 293, 479-482.
144. Smith, R.S.; Wolfgang, M.C.; Lory, S. An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia. Infect. Immun. 2004, 72, 1677-1684.
145. Lu, J.; Bao, Q.; Wu, J.; Wang, H.; Li, D.; Xi, Y.; Wang, S.; Yu, S.; Qu, J. CSCDB: the cAMP and cGMP signaling components database. Genomics 2008, 92, 60-64.
146. Galperin, M.Y. Bacterial signal transduction network in a genomic perspective. Environ. Microbiol. 2004, 6, 552-567.
147. Papadopoulos, V.; Baraldi, M.; Guilarte, T.R.; Knudsen, T.B.; Lacapere, J.J.; Lindemann, P.; Norenberg, M.D.; Nutt, D.; Weizman, A.; Zhang, M.R. et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 2006, 27, 402-409.
148. Yeliseev, A.A.; Kaplan, S. A sensory transducer homologous to the mammalian peripheral-type benzodiazepine receptor regulates photosynthetic membrane complex formation in Rhodobacter sphaeroides 2.4.1. J. Biol. Chem. 1995, 270, 21167-21175.
149. Davey, M.E.; de Bruijn, F.J. A homologue of the tryptophan-rich sensory protein TspO and FixL regulate a novel nutrient deprivation-induced Sinorhizobium meliloti locus. Appl. Environ. Microbiol. 2000, 66, 5353-5359.
150. Chapalain, A.; Chevalier, S.; Orange, N.; Murillo, L.; Papadopoulos, V.; Feuilloley, M.G. Bacterial ortholog of mammalian translocator protein (TSPO) with virulence regulating activity. PLoS ONE 2009, 4, e6096.
151. Yeliseev, A.A.; Krueger, K.E.; Kaplan, S. A mammalian mitochondrial drug receptor functions as a bacterial oxygen sensor. Proc. Natl. Acad. Sci. USA 1997, 94, 5101-5106.
152. Patel, N.J.; Zaborina, O.; Wu, L.; Wang, Y.; Wolfgeher, D.J.; Valuckaite, V.; Ciancio, M.J.; Kohler, J.E.; Shevchenko, O.; Colgan, S.P. et al. Recognition of intestinal epithelial HIF-1alpha activation by Pseudomonas aeruginosa. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G134-142.
153. Kohler, J.E.; Zaborina, O.; Wu, L.; Wang, Y.; Bethel, C.; Chen, Y.; Shapiro, J.; Turner, J.R.; Alverdy, J.C. Components of intestinal epithelial hypoxia activate the virulence circuitry of Pseudomonas. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288, G1048-1054.
154. Cogan, T.A.; Thomas, A.O.; Rees, L.E.; Taylor, A.H.; Jepson, M.A.; Williams, P.H.; Ketley, J.; Humphrey, T.J. Norepinephrine increases the pathogenic potential of Campylobacter jejuni. Gut 2007, 56, 1060-1065.
155. Lacoste, A.; Jalabert, F.; Malham, S.K.; Cueff, A.; Poulet, S.A. Stress and stress-induced neuroendocrine changes increase the susceptibility of juvenile oysters (Crassostrea gigas) to Vibrio splendidus. Appl. Environ. Microbiol. 2001, 67, 2304-2309.
156. Nakano, M.; Takahashi, A.; Sakai, Y.; Nakaya, Y. Modulation of pathogenicity with norepinephrine related to the type III secretion system of Vibrio parahaemolyticus. J. Infect. Dis. 2007, 195, 1248-1249.
157. Nakano, M.; Takahashi, A.; Sakai, Y.; Kawano, M.; Harada, N.; Mawatari, K.; Nakaya, Y. Catecholamine-induced stimulation of growth in Vibrio species. Lett. Appl. Microbiol. 2007, 44, 649-653.
158. Kowalska, K.; Carr, D.B.; Lipkowski, A.W. Direct antimicrobial properties of substance P. Life Sci. 2002, 71, 747-750.